Christian Schetter Ph.D Overview

  • Primary Position
  • Chairman

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Christian Schetter Ph.D General Information

Biography

Dr. Christian Schetter served as Chief Scientific Officer & Board Member at Rentschler Biopharma. He serves as Chairman at Eternygen. He served as Managing Director at Arix Bioscience. He also served as Board Member at Twelve Bio. He served as Chief Executive Officer and Board Member at Rigontec. He serves as Board Member at Pyxis Oncology and Aura Biosciences. He serves as Chairman at STipe Therapeutics. He joined Rigontec from Neovii Biotech, previously Fresenius Biotech, where he was President and Chief Executive Officer from 2008 until 2014. During his tenure, one antibody product was brought to market and the indication for another product expanded. Dr. Schetter was instrumental in selling Fresenius Biotech to the Neopharm Group to form Neovii Biotech and positioning it as a successful standalone business. From 1998 to 2008, he was Senior Vice President, European Operations of Coley Pharmaceutical Group, a pioneer in the development of immunostimulatory oligonucleotides, and served as Managing Director of Coley. He was part of the leadership team which built Coley Pharmaceuticals from inception through multiple financing rounds, a NASDAQ IPO and, following a number of significant pharma deals, to a trade sale to Pfizer in 2007. He received his undergraduate degree and PhD from the University of Cologne followed by a postdoctoral research in oncology and virology at the Scripps Research Institute in La Jolla, California and the Max Planck Institute in Martinsried, Germany. He is a member of the Executive Board of BIO Deutschland, the German industry association for biotech companies. He also served as Board member at OMEICOS Therapeutics.

Contact Information

Primary Position
Chairman, Eternygen
Education
University of Cologne, Ph.D. (Doctor of Philosophy)
University of Cologne, Diploma
Gender
Male
Phone
+49 030
Address
  • Karl-Liebknecht Strasse 34
  • 10178 Berlin
  • Germany
+49 030

Christian Schetter Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Eternygen Company Chairman Berlin, Germany Biotechnology

Christian Schetter Ph.D Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
Aura Biosciences Drug Discovery Publicly Held Formerly VC-backed Cambridge, MA
Eternygen Biotechnology Privately Held (backing) Venture Capital-Backed Berlin, Germany
Pyxis Other Devices and Supplies Acquired/Merged Corporate Backed or Acquired San Diego, CA
STipe Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark

Christian Schetter Ph.D Lead Partner on Deals (3)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Aura Biosciences 22-Mar-2021 Later Stage VC (Series E) Completed Drug Discovery Cambridge, MA
Twelve bio 09-Mar-2021 Completed Other Healthcare Technology Systems Copenhagen, Denmark
Pyxis Oncology 05-Mar-2021 Completed Drug Discovery Boston, MA

Christian Schetter Ph.D Network (117)

Board Members (79)

Name Company Representing Location From
Christiane Bardroff Rentschler Biopharma Rentschler Biopharma Laupheim, Germany
Shaan Gandhi Ph.D Pyxis Oncology Self Boston, MA
OMEICOS Therapeutics High-Tech Gründerfonds Berlin, Germany
STipe Therapeutics Self Copenhagen, Denmark
Pyxis Self San Diego, CA

Portfolio Executives (38)

Name Company Role Deal date Location
Conor Kilroy Aura Biosciences General Counsel, Legal & Secretary, Administration 22-Mar-2021 Cambridge, MA
Cadmus Rich MD Aura Biosciences Chief Medical Officer 22-Mar-2021 Cambridge, MA
Aura Biosciences Senior Vice President, Development 22-Mar-2021 Cambridge, MA
Aura Biosciences Chief Financial Officer 22-Mar-2021 Cambridge, MA
Aura Biosciences Director, Research 22-Mar-2021 Cambridge, MA

Christian Schetter Ph.D FAQs

  • Who is Christian Schetter Ph.D?

    Dr. Christian Schetter served as Chief Scientific Officer & Board Member at Rentschler Biopharma.

  • How much does Christian Schetter Ph.D typically invest?

    Christian Schetter Ph.D's median deal size is .

  • What is Christian Schetter Ph.D’s main position?

    Christian Schetter Ph.D’s primary position is Chairman.

  • How many active board seats does Christian Schetter Ph.D hold?

    Christian Schetter Ph.D holds 4 board seats including Aura Biosciences, Eternygen, Pyxis, and STipe Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »